Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER◆ | 27,400 | — | — | — | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | SSELL | 2,903 | $67.87 | $197K | -100.0% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | SSELL | 33,956 | $67.11 | $2.3M | -92.1% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | SSELL | 22,601 | $66.26 | $1.5M | -38.0% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | SSELL | 14,715 | $65.32 | $961.3K | -19.8% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | SSELL | 6,380 | $64.33 | $410.4K | -7.9% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER | 21,000 | $3.78 | $79.4K | +35.3% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER | 19,655 | $8.61 | $169.2K | +49.3% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER | 27,400 | $3.58 | $98.1K | +219.2% | Open the original filing on SEC.gov |
| Nov 10 | ETON | Eton Pharmaceuticals, Inc. | MEXER | 12,500 | $7.31 | $91.4K | — | Open the original filing on SEC.gov |
| Jul 31 | ETON | Eton Pharmaceuticals, Inc. | AGRANT◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | ETON | Eton Pharmaceuticals, Inc. | AGRANT◆ | 7,757 | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | ETON | Eton Pharmaceuticals, Inc. | AGRANT◆ | 12,196 | — | — | — | Open the original filing on SEC.gov |
| Dec 12, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 164,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 4, 2025 | GTBP | GT Biopharma, Inc. | AGRANT◆ | 62,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 26, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |